Filing Details
- Accession Number:
- 0001699031-25-000152
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-07-17 17:44:21
- Reporting Period:
- 2025-07-15
- Filing Date:
- 2025-07-17
- Accepted Time:
- 2025-07-17 17:44:21
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1699031 | Grail Inc. | GRAL | Services-Medical Laboratories (8071) | 863673636 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
2024196 | Aaron Freidin | C/O Grail, Inc. 1525 O'Brien Drive Menlo Park CA 94025 | Chief Financial Officer | No | Yes | No | No |
Transaction Summary
Sold: | 8,000 shares | Avg. Price: $38.93 | Total Value: $311,440.00 |
Number of Shares After Transactions: | 286,020 shares |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2025-07-15 | 8,000 | $38.93 | 286,020 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The sale transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2025.